We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+3.24%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.83%
AUM
$23.3B
AUM Growth
+$2.3B
(+11%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
8.57%
Top 10 Holdings %
Top 10 Hldgs %
7.42%
Holding
3,523
New
779
Increased
1,113
Reduced
952
Closed
661
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$175M |
| 2 |
Kroger
KR
|
+$148M |
| 3 |
Elevance Health
ELV
|
+$122M |
| 4 |
Electronic Arts
EA
|
+$120M |
| 5 |
Abbott
ABT
|
+$119M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$181M |
| 2 |
Halliburton
HAL
|
+$152M |
| 3 |
Pfizer
PFE
|
+$145M |
| 4 |
AGN
Allergan plc
AGN
|
+$124M |
| 5 |
AutoZone
AZO
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.82% |
| 2 | Technology | 12.4% |
| 3 | Consumer Discretionary | 10.17% |
| 4 | Industrials | 9.17% |
| 5 | Financials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
51
DELISTED
Alexion Pharmaceuticals
ALXN
| $91.8M | 0.39% |
786,516
+607,547
| +339% | +$86.2M |
|
52
Regeneron Pharmaceuticals
REGN
$70.6B
| $91.1M | 0.39% |
260,963
+1,170
| +0.5% | +$451K |
|
53
SBA Communications
SBAC
$18.3B
| $90.5M | 0.39% |
838,206
+113,841
| +16% | +$11.5M |
|
54
Invesco QQQ Trust
QQQ
$446B
| $89.5M | 0.38% |
832,156
+13,454
| +2% | +$1.45M |
|
55
Gaming and Leisure Properties
GLPI
$12.9B
| $87.8M | 0.38% |
2,547,777
+2,018,936
| +382% | +$66.9M |
|
56
GSK
GSK
$104B
| $84.7M | 0.36% |
1,564,156
+145,742
| +10% | +$7.68M |
|
|
STJ
57
DELISTED
St Jude Medical
STJ
| $81.9M | 0.35% |
1,049,812
-40,403
| -4% | -$2.88M |
|
|
TYC
58
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $81.5M | 0.35% |
1,826,902
+650,934
| +55% | +$27.3M |
|
59
Royal Bank of Canada
RY
$290B
| $81.3M | 0.35% |
1,381,750
+124,152
| +10% | +$7.46M |
|
60
Colgate-Palmolive
CL
$73.3B
| $81.3M | 0.35% |
1,110,159
-181,543
| -14% | -$12.9M |
|
61
Edwards Lifesciences
EW
$47.9B
| $79.5M | 0.34% |
2,391,456
+1,810,809
| +312% | +$62M |
|
62
US Bancorp
USB
$98.8B
| $78.4M | 0.34% |
1,943,247
+1,442,027
| +288% | +$60M |
|
|
YHOO
63
DELISTED
Yahoo Inc
YHOO
| $77.3M | 0.33% |
2,059,113
+1,563,913
| +316% | +$57.7M |
|
64
CVS Health
CVS
$136B
| $75.8M | 0.33% |
791,475
+756,489
| +2,162% | +$75.4M |
|
65
Akamai
AKAM
$16.3B
| $75.3M | 0.32% |
1,345,789
-494,154
| -27% | -$26M |
|
66
Toronto Dominion Bank
TD
$197B
| $75M | 0.32% |
1,753,095
+918,300
| +110% | +$40M |
|
67
J.M. Smucker
SJM
$12.9B
| $74.3M | 0.32% |
487,617
+300,317
| +160% | +$39.9M |
|
68
Manulife Financial
MFC
$72.8B
| $74.1M | 0.32% |
5,434,046
+1,010,337
| +23% | +$14.4M |
|
69
Expedia Group
EXPE
$33.5B
| $72.2M | 0.31% |
679,084
-393,901
| -37% | -$42.8M |
|
70
Eaton
ETN
$152B
| $67.7M | 0.29% |
1,133,703
-746,115
| -40% | -$45.8M |
|
71
FirstEnergy
FE
$28.5B
| $66.7M | 0.29% |
1,910,981
+494,470
| +35% | +$16.8M |
|
|
GXP
72
DELISTED
Great Plains Energy Incorporated
GXP
| $66.6M | 0.29% |
+2,191,602
| New | +$67.3M |
|
|
WCN
73
Waste Connections
WCN
$42.9B
| $65.9M | 0.28% |
1,373,280
+836,325
| +156% | +$38.1M |
|
74
PPG Industries
PPG
$26.3B
| $65.8M | 0.28% |
631,455
+19,703
| +3% | +$2.15M |
|
75
Jazz Pharmaceuticals
JAZZ
$15.9B
| $65.2M | 0.28% |
461,377
+398,023
| +628% | +$58.7M |
|
Similar funds
VAM
Two Sigma Investments's Q2 2016 Portfolio in Review
As of Q2 2016, Two Sigma Investments held 3,523 positions worth $23.3B, up 11% from $21B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
Two Sigma Investments deployed $2B of net new capital in Q2 2016, opening 779 new positions and adding to 1,113 existing holdings. Its largest new stake was Kroger: 4,100,027 shares worth $151M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Pfizer, an estimated $145M trimmed.
- Two Sigma Investments's largest Q2 2016 buy was Kroger: 4,100,027 shares worth $151M.
- Two Sigma Investments added most to Nike in Q2 2016, an estimated $175M increase.
- Two Sigma Investments's biggest Q2 2016 reduction was Pfizer, cutting an estimated $145M.
- Two Sigma Investments fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $181M.
- Two Sigma Investments's ten largest holdings make up 7.4% of its $23.3B portfolio in Q2 2016.
- Two Sigma Investments opened 779 new positions and closed 661 in Q2 2016.
- Two Sigma Investments's portfolio value rose 11% quarter-over-quarter to $23.3B.
Based on Two Sigma Investments's 13F filing for Q2 2016, filed 15 Aug 2016.